Local antibody production and respiratory syncytial virus infection in children with leukaemia.
Children undergoing therapy for acute lymphoblastic leukaemia (ALL) are at increased risk of severe viral respiratory infection, and some find it difficult to terminate virus secretion. This increased severity may result from a defect in the mucosal immune response. To test this hypothesis, nasal immunoglobulin secretion and specific antiviral antibody responses to infection with respiratory syncytial (RS) virus in children with ALL have been compared with those in a normal age-matched comparison group. Children with leukaemia secreted normal levels of IgA and slightly raised IgM levels. IgG levels were depressed. Following RS virus infection, the majority of children with leukaemia secreted normal amounts of IgA and IgG nasal antibody and successfully cleared the virus. However, three of the 13 children studied made poor or undetectable nasal antibody responses, which correlated with their inability to clear the virus.
Taylor
C E
CE
Department of Child Health, Royal Victoria Infirmary, England.
Craft
A W
AW
Kernahan
J
J
Millman
R
R
Reid
M M
MM
Scott
R
R
Toms
G L
GL
D000914:Antibodies, Viral / Q000096:biosynthesis*; D002648:Child; D002675:Child, Preschool; D004306:Dose-Response Relationship, Immunologic; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D007948:Leukemia, Monocytic, Acute / Q000150:complications / Q000276:immunology*; D009296:Nasal Cavity / Q000276:immunology / Q000382:microbiology; D012136:Respiratory Syncytial Viruses / Q000276:immunology*; D010253:Respirovirus Infections / Q000150:complications / Q000276:immunology*; D012709:Serum Albumin / Q000032:analysis
D000914:Antibodies, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D012709:Serum Albumin